$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
用AZD9291治疗期间不能吃什么?
2025-10-19 11:44:20
Check Details
AZD9291一个月多少钱?
2025-10-19 11:44:20
Check Details
靶向药AZD9291的说明书
2025-10-19 11:44:20
Check Details
AZD9291要怎么服用呢?
2025-10-19 11:44:20
Check Details
AZD9291上市的时间
2025-10-19 11:44:20
Check Details
晚期非小细胞肺癌免疫治疗进展后怎么办?新药联合方案显示活性
2025-10-19 11:44:20
Check Details
吉非替尼(Gefitinib)中文说明书
2025-10-19 11:44:20
Check Details
吉非替尼在国内什么时候上市的?
2025-10-19 11:44:20
Check Details
吉非替尼在中国的价格
2025-10-19 11:44:20
Check Details
吉非替尼上市后的价格
2025-10-19 11:44:20
Check Details
吉非替尼治疗肺癌的治疗效果如何呢?
2025-10-19 11:44:20
Check Details
吉非替尼治疗肺癌疗效怎么样呢?
2025-10-19 11:44:20
Check Details
1
2
...
3506
3507
3508
3509
3510
3511
3512
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
2
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
3
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
4
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
5
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
6
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
7
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
8
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
9
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
10
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
11
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
12
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism